Related Experiment Videos
Kinetics of 5-aza-2'-deoxycytidine phosphorylation in mouse spleen and L1210 leukemic cell extracts
Abstract:
Out of different nucleosides and deoxynucleosides testes for their ability to block the phosphorylation of labeled 5-aza-2'-deoxycytidine in the presence of ATP and the cell-free extract from mouse spleen only deoxycytidine and cytosine arabinoside depressed the reaction significantly. With the same system the phosphate donor specificity for 5-aza-2'-deoxycytidine and deoxycytidine was determined. All of the 5'-triphosphates used were less efficient donors with respect to the analogue than to the natural substrate. The apparent Michaelis constants for the phosphorylation of 5-aza-2'-deoxycytidine and deoxycytidine were 2.9 and 2.5 x 10(-5) M, respectively. Using the extract from L1210 leukemic cells the Km constant for 5-aza-2'-deoxycytidine was 6.4 x 10(-5) M and that for deoxycytidine 2.7 x 10(-5) M. The Ki constants with the spleen extract were 1.2 x 10(-3) M for 5-aza-2'-deoxycytidine and 5.8 x 10(-6) M for deoxycytidine. Both compounds acted as competitive inhibitors of one another.
Insights
Deoxycytidine and cytosine arabinoside inhibit the phosphorylation of 5-aza-2'-deoxycytidine, a potential cancer therapeutic. These nucleosides act as competitive inhibitors, impacting drug development strategies.
Area of Science:
- Biochemistry
- Pharmacology
- Cancer Research
Background:
- 5-aza-2 -deoxycytidine is an analogue of deoxycytidine used in cancer therapy.
- Understanding its metabolic pathways, particularly phosphorylation, is crucial for optimizing its efficacy.
- Inhibitors of these pathways can reveal insights into drug interactions and metabolism.
Purpose of the Study:
- To investigate the competitive inhibition of 5-aza-2 -deoxycytidine phosphorylation by other nucleosides.
- To determine the kinetic parameters (Km and Ki) of these interactions in different cellular extracts.
- To assess the phosphate donor specificity for the phosphorylation of 5-aza-2 -deoxycytidine compared to deoxycytidine.
Main Methods:
- Enzymatic assays using cell-free extracts from mouse spleen and L1210 leukemic cells.
- Testing various nucleosides and deoxynucleosides for their ability to inhibit 5-aza-2 -deoxycytidine phosphorylation.
- Determination of Michaelis constants (Km) and inhibition constants (Ki) for 5-aza-2 -deoxycytidine and deoxycytidine.
Main Results:
- Deoxycytidine and cytosine arabinoside significantly inhibited 5-aza-2 -deoxycytidine phosphorylation.
- 5 -triphosphates were less efficient phosphate donors for 5-aza-2 -deoxycytidine compared to deoxycytidine.
- Apparent Km values for 5-aza-2 -deoxycytidine and deoxycytidine phosphorylation were determined in both spleen and L1210 cell extracts.
- Ki values indicated that both compounds acted as competitive inhibitors of each other.
Conclusions:
- Deoxycytidine and cytosine arabinoside are competitive inhibitors of 5-aza-2 -deoxycytidine phosphorylation.
- These findings have implications for the development and administration of 5-aza-2 -deoxycytidine as a chemotherapeutic agent.
- Understanding competitive inhibition is key to predicting drug interactions and efficacy.